Table 2.
First stroke (n = 478) |
Recurrent stroke (n = 466) |
P-value | |
---|---|---|---|
Age | 68.47 ± 12.03 | 67.55 ± 10.51 | 0.213 |
BMI (kg/m2) | 24.18 ± 3.18 | 24.19 ± 3.04 | 0.943 |
TOAST | |||
LAA | 183 (61.8) | 231 (49.6) | 0.001 |
SVO | 113 (38.2) | 235 (50.4) | |
ICAS | 204 (80.6) | 304 (65.2) | <0.001 |
NIHSS (admission) | 3.87 ± 3.98 | 4.67 ± 3.79 | 0.002 |
NIHSS (discharge) | 3.13 ± 5.70 | 3.89 ± 4.24 | 0.025 |
mRS (discharge) | 2.36 ± 1.49 | 2.09 ± 1.33 | 0.009 |
Coronary heart disease | 37 (7.7) | 66 (29.5) | <0.001 |
HTN | 247 (51.8) | 388 (83.3) | <0.001 |
DM | 155 (32.5) | 213 (45.7) | <0.001 |
Dyslipidemia | 106 (22.2) | 305 (65.7) | <0.001 |
Alcohol drinking | 168 (35.4) | 310 (66.5) | <0.001 |
Smoking | 145 (30.6) | 330 (71.1) | <0.001 |
Overweight (BMI > 25) | 174 (36.6) | 162 (34.8) | 0.566 |
Thrombolysis | 84 (17.6) | 31 (6.7) | <0.001 |
Hb (g/dL) | 13.53 ± 2.15 | 14.10 ± 1.73 | <0.001 |
Platelet (103/μl) | 220.57 ± 72.82 | 237.03 ± 71.50 | <0.001 |
BUN (mg/dL) | 18.32 ± 10.00 | 18.42 ± 8.44 | 0.869 |
Creatinine (mg/dL) | 1.06 ± 0.77 | 1.01 ± 0.59 | 0.274 |
Total cholesterol (mg/dL) | 175.11 ± 48.12 | 162.74 ± 39.73 | <0.001 |
Triglyceride (mg/dL) | 155.78 ± 129.91 | 133.28 ± 79.33 | 0.002 |
HDL-cholesterol (mg/dL) | 43.55 ± 12.31 | 40.44 ± 17.66 | 0.002 |
LDL-cholesterol (mg/dL) | 106.09 ± 39.85 | 102.93 ± 37.94 | 0.219 |
HbA1c (%) | 7.44 ± 23.33 | 6.66 ± 1.46 | 0.475 |
Fibrinogen | 323.40 ± 83.57 | 320.25 ± 83.49 | 0.571 |
BMI, body mass index; TOAST, trial of org 10,172 in aucte stroke treatment; LAA, large artery atherosclerosis; SVO, small vessel occlusion; ICAS, intracranial arterial stenosis; NIHSS, National Institutes of Health Stroke Scale; mRS, modified Rankin scale; TIA, transient ischemic attack; HTN, hypertension; DM, diabetes mellitus. WBC, white blood cell; Hb, hemoglobin; BUN, blood urea nitrogen; HDL, high-density lipoprotein; LDL, low-density lipoprotein; HbA1c, hemoglobin A1c; CRP, C-reactive protein.